Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic
NCT ID: NCT01223872
Last Updated: 2017-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
188 participants
OBSERVATIONAL
2010-08-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Education Tools to Support Pediatric Survivor Care
NCT04257058
Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers
NCT02440737
Assessing the Acceptability of the Use of a Mobile Health App Among Young Adult Female Survivors of Childhood Cancer
NCT03242200
Childhood Cancer Survivor Study
NCT01120353
Childhood Cancer Survivor Survey
NCT00788476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Routine Patient Care
interview
* Standard Interview (2-15 years from last treatment)
* Demographic data interview (pre-initial study interview)
Previously-enrolled REACH Clinic Patients
clinic visit and interview
* REACH Clinic Visit(initial or regular)
* Post-REACH Clinic Interview (3mos from initial or regular clinic visit)
* Demographic data interview(pre-initial study interview)
New REACH Clinic Patients
interviews and clinic visit
* Pre-REACH Clinic Interview(2-15 yrs from last treatment)
* REACH Clinic Visit(initial or regular)
* Post-REACH Clinic Interview(1mo from initial clinic visit)
* Post-REACH Clinic Interview(3mos from initial or regular clinic visit)
* Demographic data interview(pre-initial study interview)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
interview
* Standard Interview (2-15 years from last treatment)
* Demographic data interview (pre-initial study interview)
clinic visit and interview
* REACH Clinic Visit(initial or regular)
* Post-REACH Clinic Interview (3mos from initial or regular clinic visit)
* Demographic data interview(pre-initial study interview)
interviews and clinic visit
* Pre-REACH Clinic Interview(2-15 yrs from last treatment)
* REACH Clinic Visit(initial or regular)
* Post-REACH Clinic Interview(1mo from initial clinic visit)
* Post-REACH Clinic Interview(3mos from initial or regular clinic visit)
* Demographic data interview(pre-initial study interview)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≤ 21 years at time of diagnosis
* Currently alive without evidence of disease
* Off therapy for no more than 15 years
Exclusion Criteria
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VICCREACH1038
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.